References
1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with
pneumonia in China, 2019. New England Journal of Medicine. 2020.
2. Wu Z, McGoogan JM. Characteristics of and important lessons from the
coronavirus disease 2019 (COVID-19) outbreak in China: summary of a
report of 72 314 cases from the Chinese Center for Disease Control and
Prevention. Jama. 2020;323(13):1239-1242.
3. Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in children in
early January 2020 in Wuhan, China. New England Journal of
Medicine. 2020;382(14):1370-1371.
4. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased
patients with coronavirus disease 2019: retrospective study. Bmj.2020;368.
5. Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients
recovered from COVID-19. Jama. 2020;323(15):1502-1503.
6. Meng J, Xiao G, Zhang J, et al. Renin-angiotensin system inhibitors
improve the clinical outcomes of COVID-19 patients with hypertension.Emerging microbes & infections. 2020;9(1):757-760.
7. Yanrong W, Yingxia L, Lei L, Xianfeng W, Nijuan L, Ling L. Clinical
Outcomes in 55 Patients With Severe Acute Respiratory Syndrome
Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen,
China. The Journal of Infectious Diseases. 2020.
8. Zhang X, Tan Y, Ling Y, et al. Viral and host factors related to the
clinical outcome of COVID-19. Nature. 2020:1-7.
9. Urbanowicz RA, McClure CP, Sakuntabhai A, et al. Human adaptation of
Ebola virus during the West African outbreak. Cell.2016;167(4):1079-1087. e1075.